VIAV vs. ZBH
VIAV (Viavi Solutions Inc.) and ZBH (Zimmer Biomet Holdings, Inc.) are both stocks. VIAV operates in Communication Equipment (Technology), while ZBH operates in Medical Devices (Healthcare). Over the past 10 years, VIAV returned 22.52%/yr vs -2.46%/yr for ZBH. At a 0.33 correlation, their price movements are largely independent.
Performance
VIAV vs. ZBH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VIAV achieves a 194.16% return, which is significantly higher than ZBH's -5.24% return. Over the past 10 years, VIAV has outperformed ZBH with an annualized return of 22.52%, while ZBH has yielded a comparatively lower -2.46% annualized return.
VIAV
- 1D
- -0.87%
- 1M
- -0.13%
- YTD
- 194.16%
- 6M
- 199.37%
- 1Y
- 463.66%
- 3Y*
- 73.77%
- 5Y*
- 24.82%
- 10Y*
- 22.52%
ZBH
- 1D
- 1.47%
- 1M
- 2.79%
- YTD
- -5.24%
- 6M
- -8.23%
- 1Y
- -6.51%
- 3Y*
- -12.39%
- 5Y*
- -10.52%
- 10Y*
- -2.46%
VIAV vs. ZBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VIAV Viavi Solutions Inc. | 194.16% | 76.44% | 0.30% | -4.19% | -40.35% | 17.66% | -0.17% | 49.25% | 14.99% | 6.85% |
ZBH Zimmer Biomet Holdings, Inc. | -5.24% | -14.03% | -12.46% | -3.81% | 4.24% | -17.02% | 3.77% | 45.37% | -13.30% | 17.86% |
Correlation
The correlation between VIAV and ZBH is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Aug 5, 2015 | 0.33 |
Over the past year, the correlation between VIAV and ZBH has dropped to 0.07 - well below their long-term average of 0.33, suggesting their price drivers have been diverging.
Fundamentals
VIAV:
$13.08B
ZBH:
$16.64B
VIAV:
-$0.24
ZBH:
$3.85
VIAV:
8.86
ZBH:
2.00
VIAV:
15.45
ZBH:
1.13
VIAV:
$1.37B
ZBH:
$8.41B
VIAV:
$767.90M
ZBH:
$5.89B
VIAV:
$88.40M
ZBH:
$2.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VIAV vs. ZBH — Risk / Return Rank
VIAV
ZBH
VIAV vs. ZBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Viavi Solutions Inc. (VIAV) and Zimmer Biomet Holdings, Inc. (ZBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VIAV | ZBH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +7.93 | ||
| Sortino ratioReturn per unit of downside risk | +6.37 | ||
| Omega ratioGain probability vs. loss probability | 1.90 | 0.99 | +0.91 |
| Calmar ratioReturn relative to maximum drawdown | 22.13 | -0.26 | +22.38 |
| Martin ratioReturn relative to average drawdown | 84.46 | -0.51 | +84.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| VIAV | ZBH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 7.72 | -0.22 | +7.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.59 | -0.40 | +0.99 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.59 | -0.09 | +0.68 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.18 | +0.39 |
Drawdowns
VIAV vs. ZBH - Drawdown Comparison
The maximum VIAV drawdown since its inception was -62.88%, roughly equal to the maximum ZBH drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for VIAV and ZBH.
Loading charts...
Drawdown Indicators
| VIAV | ZBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.88% | -65.03% | +2.15% |
Max Drawdown (1Y)Largest decline over 1 year | -21.13% | -25.54% | +4.41% |
Max Drawdown (3Y)Largest decline over 3 years | -42.19% | -43.94% | +1.75% |
Max Drawdown (5Y)Largest decline over 5 years | -62.88% | -48.62% | -14.26% |
Max Drawdown (10Y)Largest decline over 10 years | -62.88% | -52.14% | -10.74% |
Current DrawdownCurrent decline from peak | -5.26% | -48.89% | +43.63% |
Average DrawdownAverage peak-to-trough decline | -19.93% | -20.05% | +0.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.53% | 12.72% | -7.19% |
Volatility
VIAV vs. ZBH - Volatility Comparison
Viavi Solutions Inc. (VIAV) has a higher volatility of 20.21% compared to Zimmer Biomet Holdings, Inc. (ZBH) at 7.44%. This indicates that VIAV's price experiences larger fluctuations and is considered to be riskier than ZBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VIAV | ZBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.21% | 7.44% | +12.77% |
Volatility (6M)Calculated over the trailing 6-month period | 51.87% | 20.09% | +31.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.58% | 30.38% | +30.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.45% | 26.60% | +15.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.18% | 28.43% | +9.75% |
Dividends
VIAV vs. ZBH - Dividend Comparison
VIAV has not paid dividends to shareholders, while ZBH's dividend yield for the trailing twelve months is around 1.13%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VIAV Viavi Solutions Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 77.01% |
ZBH Zimmer Biomet Holdings, Inc. | 1.13% | 1.07% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% |
Financials
VIAV vs. ZBH - Financials Comparison
This section allows you to compare key financial metrics between Viavi Solutions Inc. and Zimmer Biomet Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VIAV vs. ZBH - Profitability Comparison
VIAV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Viavi Solutions Inc. reported a gross profit of 234.10M and revenue of 406.80M. Therefore, the gross margin over that period was 57.6%.
ZBH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.51B and revenue of 2.09B. Therefore, the gross margin over that period was 72.4%.
VIAV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Viavi Solutions Inc. reported an operating income of 24.80M and revenue of 406.80M, resulting in an operating margin of 6.1%.
ZBH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported an operating income of 373.20M and revenue of 2.09B, resulting in an operating margin of 17.9%.
VIAV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Viavi Solutions Inc. reported a net income of 6.40M and revenue of 406.80M, resulting in a net margin of 1.6%.
ZBH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zimmer Biomet Holdings, Inc. reported a net income of 238.10M and revenue of 2.09B, resulting in a net margin of 11.4%.
Frequently Asked Questions
VIAV and ZBH have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VIAV has higher volatility (20.21%) compared to ZBH (7.44%). In terms of maximum drawdown, VIAV dropped -62.88% vs ZBH's -65.03%.
VIAV currently has the higher Sharpe Ratio (7.72 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VIAV and ZBH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer